1. Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany;
2. Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany;
3. Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University Medical School, Aachen, Germany;
4. Division of Hematology and Hemostaseology, Department of Internal Medicine I, and
5. Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria;
6. Institute of Neuroscience and Medicine, Institute for Advanced Simulation, Jülich, Germany;
7. Jülich Supercomputing Centre, Research Centre Jülich, Jülich, Germany;
8. Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland;
9. iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland;
10. Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland;
11. Institute of Pathology and
12. Institute for Human Genetics, RWTH Aachen University Hospital, Aachen, Germany;
13. Helmholtz-Institute for Biomedical Engineering, Stem Cell Biology and Cellular Engineering, RWTH Aachen University Medical School, Aachen, Germany;
14. Department of Hematology and Oncology, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany; and
15. Department of Pharmacology, Boehringer Ingelheim RCV, Vienna, Austria